Zevalin (IDEC Pharmaceuticals) en es it fr

Zevalin (IDEC Pharmaceuticals) Brand names, Zevalin (IDEC Pharmaceuticals) Analogs

Zevalin (IDEC Pharmaceuticals) Brand Names Mixture

  • No information avaliable

Zevalin (IDEC Pharmaceuticals) Chemical_Formula

C6382H9830N1672O1979S54

Zevalin (IDEC Pharmaceuticals) RX_link

http://www.rxlist.com/cgi/generic3/zevalin.htm

Zevalin (IDEC Pharmaceuticals) fda sheet

Zevalin (IDEC Pharmaceuticals) msds (material safety sheet)

Zevalin (IDEC Pharmaceuticals) Synthesis Reference

No information avaliable

Zevalin (IDEC Pharmaceuticals) Molecular Weight

143375.5

Zevalin (IDEC Pharmaceuticals) Melting Point

61 oC (FAB fragment), 71 oC (whole mAb) - Vermeer, A.W.P. & Norde, W., Biophys. J. 78:394-404 (2000).

Zevalin (IDEC Pharmaceuticals) H2O Solubility

No information avaliable

Zevalin (IDEC Pharmaceuticals) State

Liquid

Zevalin (IDEC Pharmaceuticals) LogP

-0.359

Zevalin (IDEC Pharmaceuticals) Dosage Forms

Solution (IV Infusion)

Zevalin (IDEC Pharmaceuticals) Indication

For treatment of non-Hodgkin's lymphoma

Zevalin (IDEC Pharmaceuticals) Pharmacology

Zevalin binds to the CD20 antigen, which is predominantly expressed on mature B cells and on >90% of B-cell non-Hodgkin's lympohomas. The antibody leads to selective killing of B-cells.

Zevalin (IDEC Pharmaceuticals) Absorption

No information avaliable

Zevalin (IDEC Pharmaceuticals) side effects and Toxicity

No information avaliable

Zevalin (IDEC Pharmaceuticals) Patient Information

No information avaliable

Zevalin (IDEC Pharmaceuticals) Organisms Affected

Humans and other mammals